A New Way to Lock Peptides into Shape — and Make Them Glow — for Drug Development and Cell Imaging | Research

The takeaway

A new peptide stapling method locks peptides into their active shape using natural amino acids while simultaneously making them fluorescent for cell imaging, with the stapled peptide matching the potency of existing methods.

IC50 = 5.10 μM
The FlICk-stapled peptide matched the cell-killing potency of a conventional olefin-stapled peptide, validating the new method while adding built-in fluorescence.

What the researchers found

Researchers developed a new method for "stapling" peptides — chemically locking them into their active helical shape — that works on unprotected peptides using natural amino acid residues (lysine and cysteine). The technique, called FlICk (Fluorescent Isoindole Crosslink), uses a three-component reaction that is rapid, mild, and highly selective. A key bonus: the staple itself is fluorescent, emitting blue-green light that allows researchers to directly image the peptide inside cells without needing to attach a separate fluorescent tag. A FlICk-stapled peptide showed cytotoxicity with an IC50 of 5.10 μM, matching the potency of a conventional olefin-stapled version.

Why it matters

Many important drug targets involve protein-protein interactions — large, flat surfaces that are notoriously difficult to block with small molecules. Stapled peptides can disrupt these interactions by mimicking the helical shape of natural protein partners. However, current stapling methods often require non-natural amino acids or complex protection chemistry. This new approach works with natural amino acids on unprotected peptides and produces a built-in fluorescent reporter, simplifying both the synthesis and the evaluation of stapled peptide drugs.

The numbers in context

IC50 = 5.10 ± 1.27 μM for FlICk-stapled peptide · i, i+4 positional selectivity · Lysine-cysteine crosslink

How the study worked

The researchers synthesized stapled peptides using 2-arylketobenzaldehydes (ArKBCHOs) as molecular linchpins in a three-component reaction with lysine and cysteine residues on unprotected peptides. They characterized the selectivity (chemo-, regio-, and positional) of the stapling reaction, measured in vitro cytotoxicity of the stapled peptides, and leveraged the inherent fluorescence of the thiol-isoindole crosslink for cellular imaging to assess cell permeability.

Who was studied

Not applicable — in vitro chemistry and cell-based experiments

What this study cannot tell us

This is early-stage chemistry research with only in vitro validation. Cytotoxicity was demonstrated for one peptide target, and it's unclear how broadly the technique applies across different peptide sequences. Cell permeability was assessed via imaging but not quantified with uptake assays. No in vivo studies or pharmacokinetic data were presented. The long-term stability of the fluorescent staple in biological environments is not addressed.

How to read the evidence

This is a chemistry methodology paper with in vitro biological validation for one peptide. While the chemistry is well-characterized, the therapeutic relevance is demonstrated in only a single example, and no animal or human studies have been conducted.

When this study was published

Published in 2025, this is a cutting-edge development in peptide chemistry. Stapled peptide technology is actively evolving, and this method addresses key limitations of existing approaches.

The bigger picture

Stapled peptides are one of the most promising approaches for tackling "undruggable" protein-protein interactions in cancer, infectious disease, and other conditions. The field has been limited by the need for non-natural amino acids and complex synthetic procedures. Methods like FlICk that work with natural residues and add functionality (fluorescence) without extra steps could accelerate the development of stapled peptide therapeutics and make the technology more accessible to research labs worldwide.

Questions still open

How broadly does the FlICk stapling method work across different peptide sequences and target proteins beyond the one demonstrated?
Is the fluorescent staple stable enough in biological environments for in vivo imaging applications?
Could this dual-purpose approach — therapeutic stapled peptide plus built-in imaging probe — be used in clinical diagnostics or theranostics?

Common questions

What is peptide stapling and why does it matter?

Peptide stapling is a chemical technique that locks a peptide into its active helical (corkscrew) shape using a chemical crosslink. This matters because many peptides lose their shape — and their ability to bind targets — when removed from their natural protein context. Stapling restores their structure and often improves their ability to enter cells and resist degradation.

Why is it useful that the staple is fluorescent?

Normally, researchers need to attach a separate fluorescent dye to track a peptide inside cells, which can change the peptide's behavior. With the FlICk method, the staple itself glows, so researchers can directly see where the peptide goes inside cells without adding anything extra — simplifying experiments and providing more accurate results.

Read the original research

Chemoselective, regioselective, and positionally selective fluorogenic stapling of unprotected peptides for cellular uptake and direct cell imaging.

Chemical science, 16(2), 584-595

View on PubMed ↗Publisher’s paper ↗

Citation

Dayanara, Naysilla L; Froelich, Juliette; Roome, Pascale; Perrin, David M. (2025). Chemoselective, regioselective, and positionally selective fluorogenic stapling of unprotected peptides for cellular uptake and direct cell imaging.. Chemical science, 16(2), 584-595. https://doi.org/10.1039/d4sc04839c